Obinutuzumab Biosimilar - Research Grade
Product Specifications
Background
Product Name Alternative
MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7, membrane spanning 4-domains A1, FMC7
UniProt
P11836
Host
Humanized
Reactivity
Human
Target
CD20
Isotype
IgG1
Sequence
https://www.imgt.org/mAb-DB/
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
1.0 - 5.0 mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE and HPLC
Buffer
ICH3001-100ml ICH3002-100ml ICH3003-100ml
Shipping Conditions
Blue ice
Storage Conditions
Specificity
Detects human CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Obinutuzumab/afutuzumab.
Formulation
Phosphate buffered saline (PBS) pH 7.2, with no carrier protein, potassium or preservatives added. BSA and Azide free.
Isotype Control
Bulk Human IgG1 Isotype Control (IB1) [ICH2254]
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NFKB p65 Recombinant Antibody, PE-Cy7 Conjugated
NFKB p65 Recombinant Antibody, PE-Cy7 Conjugated
Recombinant Archaeoglobus fulgidus F420-dependent methylenetetrahydromethanopterin dehydrogenase (mtd)